References
- Ohta M, Inoue H, Cotticelli MG, et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and carcinoma-associated translocation breakpoint is abnormal in digestive tract cancers. Cell 1996; 84: 587–97
- Sozzi G, Veronese ML, Negrini M, et al. The FHIT gene at 3p14.2 is abnormal in lung cancer. Cell 1996; 85: 17–26
- Roz L, Gramegna M, Ishii H, et al. Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines. Proc Natl Acad Sci USA 2002; 99: 3615–20
- Gotte K, Hadaczek P, Coy JF, et al. Fhit expression is absent or reduced in a subset of primary head and neck cancer. Anticancer Res 2000; 20: 1057–60
- Moore PS, Beghelli S, Zamboni G, et al. Genetic abnormalities in pancreatic cancer. Mol Cancer 2003; 2: 7–12
- Stam RW, den Boer ML, Passier MM, et al. Silencing of the tumor suppressor gene FHIT is highly characteristic for MLL gene rearranged infant acute lymphoblastic leukemia. Leukemia 2006; 20: 264–71
- Foja S, Goldberg M, Schagdarsurengin U, et al. Promoter methylation and loss of coding exons of the fragile histidine triad (FHIT) gene in intrahepatic cholangiocarcinomas. Liver Int 2005; 25: 1202–8
- Vecchione A, Sevignani C, Giarnieri E, et al. Inactivation of the FHIT gene favors bladder cancer development. Clin Cancer Res 2004; 10: 7607–12
- Sevignani C, Calin GA, Cesari R, et al. Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in breast cancer cell lines. Cancer Res 2003; 63: 1183–7
- Fong LY, Fidanza V, Zanesi N, et al. Murr-Torre-like syndrome in Fhit-deficient mice. Proc Natl Acad Sci USA 2000; 98: 4742–7
- Siprashvili Z, Sozzi G, Barnes LD, et al. Replacement of FHIT in cancer cells suppressed tumorigenicity. Proc Natl Acad Sci USA 1997; 94: 13771–6
- Ji L, Fang BL, Yen N, et al. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT). Cancer Res 1999; 59: 3333–9
- Sard L, Accornero P, Tornieli S, et al. The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control. Proc Natl Acad Sci USA 1999; 96: 8489–92
- Spiro RH, Huvos AG, Berk R. Mucoepidermoid carcinoma of salivary gland origin. Am J Surg 1978; 136: 461–8
- Wu JZ, Situ ZQ, Liu ZB, et al. Selection and characterization of a highly metastatic cell clone from mucoepidermoid carcinoma cell line derived from human salivary gland. Chin Dent Res 1998; 1: 71–7
- Semba S, Huebner K. Protein expression profiling identifies cyclophilin A as a molecular target in Fhit-mediated tumor suppression. Mol Cancer Res 2006; 4: 529–38
- Louise B, Mohammed AK, Andrew NF, et al. Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer. Cancer Res 1998; 58: 2533–6
- Dumon KR, Ishii H, Vecchione A, et al. Fragile histidine triad expression delays tumor development and induces apoptosis in human pancreatic cancer. Cancer Res 2001; 61: 4827–36